Cargando…

Predictors of severity and outcome of multiple sclerosis relapses

BACKGROUND: Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). The most common type of MS is the relapsing–remitting MS (RRMS) where relapses are the main component of the disease course. However, the relationship between the characteristics of the relapses on on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosny, Hassan Saad, Shehata, Hatem Samir, Ahmed, Sandra, Ramadan, Ismail, Abdo, Sarah Sherif, Fouad, Amr Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926556/ https://www.ncbi.nlm.nih.gov/pubmed/36782141 http://dx.doi.org/10.1186/s12883-023-03109-6

Ejemplares similares

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
por: Hamdy, Sherif M, et al.
Publicado: (2017)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
por: Elmazny, Alaa, et al.
Publicado: (2020)

Behavior and awareness of multiple sclerosis patients during COVID-19 pandemic in a tertiary center in Egypt
por: Nada, Mona, et al.
Publicado: (2021)

Could SARS-CoV-2 herald a surge of multiple sclerosis?
por: Shalaby, Nevin Mohieldin, et al.
Publicado: (2021)

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
por: Hamdy, Sherif M, et al.
Publicado: (2020)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
por: Hamdy, Sherif M, et al.
Publicado: (2018)

Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis
por: Koraysha, Noha Abo, et al.
Publicado: (2019)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery
por: Mowry, Ellen M., et al.
Publicado: (2013)

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020)

Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis
por: Elgendy, Sherein G., et al.
Publicado: (2021)

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis
por: Nicholas, Jacqueline, et al.
Publicado: (2020)

Repair of very severe tricuspid regurgitation following detachment of the tricuspid valve
por: Mahgoub, Ahmed, et al.
Publicado: (2015)

Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience
por: Guerra, Tommaso, et al.
Publicado: (2022)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

Factors Involved in Relapse of Multiple Sclerosis
por: Kamel, Fatemah Omar
Publicado: (2019)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Evaluating sex hormones and cytokine profile in Egyptian females with relapsing-remitting multiple sclerosis
por: Talaat, Forayssa M., et al.
Publicado: (2018)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

Jacksonian seizure as the relapse symptom of multiple sclerosis
por: Najafi, Mohammad Reza, et al.
Publicado: (2013)

Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care
por: Asano, Miho, et al.
Publicado: (2015)

Systematic literature review and network meta-analysis in highly active relapsing–remitting multiple sclerosis and rapidly evolving severe multiple sclerosis
por: Huisman, Eline, et al.
Publicado: (2017)

The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
por: Kishk, Nirmeen A., et al.
Publicado: (2021)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Management of unstable pertrochanteric fractures, evaluation of forgotten treatment options
por: Selim, Amr Ahmed Hosny Abdo, et al.
Publicado: (2020)

A Rare Case of Ipsilateral Floating Hip with Femoral Neck Fracture and Contralateral Floating Knee Injury – Proposal for a Management Flowchart and Literature Review
por: Selim, Amr Ahmed Hosny Abdo, et al.
Publicado: (2020)

Predictors of Attack Severity and Duration in Multiple Sclerosis: A Prospective Study
por: Naldi, P, et al.
Publicado: (2011)

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis
por: Wu, Qi, et al.
Publicado: (2021)

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
por: Alroughani, R., et al.
Publicado: (2013)

Characterization of morphology and function of the ‘neo-atria’ after a modified Mustard operation
por: Nagy, Mohamed, et al.
Publicado: (2021)

The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis
por: Mardiguian, Silvy, et al.
Publicado: (2017)

A voxel-based morphometry study of disease severity correlates in relapsing–remitting multiple sclerosis
por: Prinster, A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_obdtlovtk47tuih50p8hqcbgp5